Hyderabad, India, January 11, 2010  

Dr. Reddy's to release Q3 FY10 results on Jan 20, 2010
Earnings call slated for Jan 20, 6.30 PM IST / 8.00 AM EST

Hyderabad, India, January 11, 2010: Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the Third quarter ended December 31, 2009 on Wednesday, January 20, 2010 after the Board Meeting. The results will be available on the Company’s website

Summary of Events

Event Date and Time (IST) Medium

Release of financial results

January 20, after the Board Meeting

Email, Media, Company website, Businesswire

Earnings Call

January 20, 6.30 PM IST / 8:00 AM EST

Hosted by the Company
(Details below)

Webcast of Earnings Call

January 20, 6.30 PM IST / 8.00 AM EST through January 25, 2010

URL available on Company’s website,

Transcripts of the Earnings call

Will be available on the Company’s website

URL available on Company’s website,

Earnings Call
Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.

Conference Dial-In Numbers

Primary Number:
Secondary Number:

+91 22 4039 2525
+91 22 6629 0101

The numbers listed above are universally accessible from all networks and all countries.
Local Access Number:

3940 3977
Available in - Gurgaon (NCR), Bangalore, Kolkata, Cochin, Pune
Accessible from all carriers.

6000 1221
Available in - Chennai, Hyderabad
Accessible from all major carriers except BSNL/MTNL.

* The Local Access Number is accessible from all major carriers except BSNL/MTNL
International Toll Free Number: USA: 1 866 746 2133
UK: 0 808 101 1573
Singapore: 800 101 2045
Hong Kong: 800 964 448

No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.

Audio Webcast
The audio webcast of the earnings call will be available to all interested parties at Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through January 25, 2010. For play back dial in phone No: 022 3065 1212 and ID: 375#.

The transcript of the earnings call will also be available on the Company's website.

About Dr Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company with proven basic research capabilities. The company develops, manufactures and markets a wide range of pharmaceutical products in India and overseas. Dr. Reddy’s produces finished dosage forms, active pharmaceutical ingredients, diagnostic kits, critical care and biotechnology products. The basic research program of Dr. Reddy’s focuses on cancer, diabetes, bacterial infections and pain management. Website:

For further information please contact:
Investor Relations:
Kedar Upadhye
at /+91 40 66834297
Raghavender R at /+91 40 66511529  
Milan Kalawadia (USA) at / +1 9082034931